Toyota Motor Corp/
TM NYSE Motor Vehicles & Passenger Car Bodies Financials FY2020–FY2026
Last close · Oct 23, 2026
$196.79
0.7%What Toyota Motor Corp/ does
No business description yet.
- Legal name
- TOYOTA MOTOR CORP/
- Fiscal year ends
- March 31, 2026
- Latest annual report
- 20-F · Jun 10, 2026
- Accession · CIK
- 0001193125-26-264811
0001094517
Revenue and margins
Toyota Motor Corp/ had $336.2B of revenue in fiscal 2026, up 6.7% on the year before.
Net income and earnings per share
From fiscal 2020 to 2026, diluted EPS grew 6.7% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was — in fiscal 2026, — of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Toyota Motor Corp/ returned $8.2B to shareholders in fiscal 2026. The diluted share count fell 1.7%.
Balance sheet
Cash, debt and the ratios that show how comfortably Toyota Motor Corp/ can carry it.
| Fiscal year end | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Cash and short-term investments | $50.2B | $56.4B | $62.3B | $60.1B | $79.4B |
| Debt incl. finance leases | $217.6B | $220.6B | $241.8B | $259.6B | $270.9B |
| Net debt / EBITDA | 3.9x | 4.7x | 3.5x | 4.3x | 4.7x |
| Debt / equity | 1.0x | 1.0x | 1.1x | 1.1x | 1.1x |
| Interest coverage | 7.3x | 4.2x | 4.4x | 2.9x | 2.2x |
| Current ratio | 1.1x | 1.1x | 1.2x | 1.3x | 1.3x |
| Quick ratio | 0.9x | 0.9x | 1.0x | 1.1x | 1.1x |
| Total assets | $555.9B | $557.9B | $596.0B | $626.4B | $661.6B |
| Total liabilities | $332.9B | $338.2B | $363.0B | $379.6B | $404.4B |
| Shareholders' equity | $215.5B | $212.8B | $226.3B | $240.4B | $250.3B |
| Net debt (− = net cash) | $167.4B | $164.2B | $179.6B | $199.5B | $191.5B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. “Plan” marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
—
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.
| Test | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|
| Net income is positive | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| Cash from operations is positive | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| Return on assets rose | — | ✓ | ✓ | ✕ | ✓ | ✕ | ✕ |
| Cash from operations exceeds net income | ✓ | ✓ | ✓ | ✓ | ✕ | ✕ | ✓ |
| Debt fell relative to assets | — | ✕ | ✓ | ✕ | ✕ | ✕ | ✓ |
| Current ratio rose | — | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| Share count didn't rise | — | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| Gross margin rose | — | — | — | — | — | — | — |
| Revenue rose relative to assets | — | ✕ | ✓ | ✕ | ✓ | ✕ | ✓ |
| F-score | — / 3 | 6 / 8 | 8 / 8 | 5 / 8 | 6 / 8 | 4 / 8 | 7 / 8 |
| Accruals ratio | −0.7% | −0.9% | −1.4% | −0.7% | 0.9% | 1.1% | −1.7% |
| Altman Z'' | 2.40 | 2.30 | 2.46 | 2.37 | 2.66 | 2.79 | 2.67 |
7 years of figures
Amounts in USD. Hover a ratio’s name for its definition.
| Fiscal year | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | $274.8B | $256.7B | $279.3B | $274.3B | $312.0B | $315.1B | $336.2B |
| Research and development | $10.1B | $10.2B | $9.7B | $9.0B | $8.6B | $9.0B | $10.4B |
| Operating income | $22.1B | $20.7B | $26.7B | $20.1B | $37.0B | $31.5B | $25.0B |
| Interest expense | $4.8B | $4.4B | $3.7B | $4.8B | $8.4B | $10.9B | $11.3B |
| Pretax income | $25.7B | $27.7B | $35.5B | $27.1B | $48.2B | $42.1B | $34.2B |
| Income tax | $6.3B | $6.1B | $9.9B | $8.7B | $13.1B | $10.7B | $7.7B |
| Net income | $18.7B | $21.2B | $25.4B | $18.1B | $34.2B | $31.3B | $25.5B |
| Net income to common | $18.7B | $21.2B | $25.4B | $18.1B | $34.2B | $31.3B | $25.5B |
| Diluted EPS | $13.25 | $14.99 | $18.27 | $13.25 | $25.32 | $23.59 | $19.59 |
| Diluted shares | 1.40B | 1.40B | 1.39B | 1.37B | 1.35B | 1.33B | 1.30B |
| Cash flow | |||||||
| Cash from operations | $22.1B | $25.7B | $33.1B | $21.8B | $29.1B | $24.3B | $36.3B |
| Depreciation and amortization | $14.7B | $15.5B | $16.2B | $15.1B | $14.4B | $14.8B | $15.9B |
| Dividends paid | $5.7B | $5.9B | $6.3B | $5.4B | $6.1B | $7.4B | $8.2B |
| Dividends and buybacks | $5.7B | $5.9B | $6.3B | $5.4B | $6.1B | $7.4B | $8.2B |
| Balance sheet | |||||||
| Cash and short-term investments | $37.8B | $46.0B | $50.2B | $56.4B | $62.3B | $60.1B | $79.4B |
| Total debt | $196.6B | $231.6B | $217.6B | $220.6B | $241.8B | $259.6B | $270.9B |
| Current assets | $174.7B | $205.6B | $194.8B | $198.7B | $229.6B | $248.1B | $268.5B |
| Current liabilities | $167.2B | $193.7B | $179.4B | $179.9B | $193.0B | $197.0B | $210.7B |
| Inventory | $23.3B | $26.1B | $31.4B | $32.0B | $30.5B | $30.8B | $32.2B |
| Property and equipment, net | $97.1B | $103.0B | $101.2B | $94.9B | $94.3B | $102.6B | $107.0B |
| Total assets | $497.3B | $562.0B | $555.9B | $557.9B | $596.0B | $626.4B | $661.6B |
| Total liabilities | $300.7B | $342.8B | $332.9B | $338.2B | $363.0B | $379.6B | $404.4B |
| Shareholders' equity | $190.0B | $211.2B | $215.5B | $212.8B | $226.3B | $240.4B | $250.3B |
| Margins | |||||||
| Operating margin | 8.0% | 8.1% | 9.5% | 7.3% | 11.9% | 10.0% | 7.4% |
| EBITDA margin | 13.4% | 14.1% | 15.4% | 12.8% | 16.5% | 14.7% | 12.2% |
| Net margin | 6.8% | 8.3% | 9.1% | 6.6% | 11.0% | 9.9% | 7.6% |
| Returns | |||||||
| Return on capital | 4.8% | 4.1% | 5.0% | 3.6% | 6.6% | 5.3% | 4.4% |
| Return on capital employed | 6.7% | 5.6% | 7.1% | 5.3% | 9.2% | 7.3% | 5.5% |
| Return on equity | 9.9% | 10.6% | 11.9% | 8.4% | 15.6% | 13.4% | 10.4% |
| Return on assets | 3.8% | 4.0% | 4.5% | 3.2% | 5.9% | 5.1% | 4.0% |
| Return on tangible equity | 9.9% | 10.0% | 11.8% | 8.5% | 15.1% | 13.0% | 10.2% |
| Growth | |||||||
| Revenue growth | — | −6.6% | 8.8% | −1.8% | 13.8% | 1.0% | 6.7% |
| Net income growth | — | 13.1% | 19.8% | −28.7% | 89.1% | −8.6% | −18.3% |
| EPS growth | — | 13.1% | 21.9% | −27.5% | 91.1% | −6.8% | −17.0% |
| Share count change | — | −0.1% | −0.6% | −1.6% | −1.1% | −1.9% | −1.7% |
| Financial health | |||||||
| Net debt / EBITDA | 4.3x | 5.1x | 3.9x | 4.7x | 3.5x | 4.3x | 4.7x |
| Debt / equity | 1.0x | 1.1x | 1.0x | 1.0x | 1.1x | 1.1x | 1.1x |
| Interest coverage | 4.6x | 4.7x | 7.3x | 4.2x | 4.4x | 2.9x | 2.2x |
| Current ratio | 1.0x | 1.1x | 1.1x | 1.1x | 1.2x | 1.3x | 1.3x |
| Quick ratio | 0.9x | 0.9x | 0.9x | 0.9x | 1.0x | 1.1x | 1.1x |
| Quality scores | |||||||
| Piotroski F-score | — | 6.0 | 8.0 | 5.0 | 6.0 | 4.0 | 7.0 |
| Altman Z'' | 2.4 | 2.3 | 2.5 | 2.4 | 2.7 | 2.8 | 2.7 |
| Accruals ratio | −0.7% | −0.9% | −1.4% | −0.7% | 0.9% | 1.1% | −1.7% |
Source: SEC EDGAR XBRL filings (CIK 0001094517). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. Filed in JPY under IFRS and converted to US$: income and cash-flow lines at each period's average exchange rate, balance-sheet lines at the period-end rate. Per-share figures are per US-listed share (1 ADS = 10 ordinary shares). For information only — not investment advice. Check the original filings before relying on any figure.
